Array Technologies, Inc.

Equities

ARRY

US04271T1007

Renewable Energy Equipment & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
11.69 ^USD	+3.73%		-3.71%	-30.42%

Apr. 11	Piper Sandler Adjusts Price Target on Array Technologies to $13 From $12, Maintains Neutral Rating	MT
Apr. 10	Array Technologies, Inc. Announces Not Standing for Re-Election of Board of Directors	CI

Array BioPharma : To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences

November 25, 2014 at 02:01 pm EST

BOULDER, Colo., Nov. 25, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO



    Event:                             Piper Jaffray 2014 Healthcare
                                       Conference

    Date:                             Wednesday, December 3, 2014

    Time:                             1:30 p.m.  Eastern Time

    Location:                         Palace Hotel, New York City


    Event:                             Oppenheimer 25th Annual
                                       Healthcare Conference

    Date:                             Wednesday, December 10, 2014

    Time:                             11:30 a.m.  Eastern Time

    Location:                          Crowne Plaza Times Square
                                       Manhattan, New York City

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.



    CONTACT:                              Tricia Haugeto

                                          Array BioPharma Inc.

                                          303-386-1193

                                          thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-piper-jaffray-and-oppenheimer-2014-healthcare-conferences-300001129.html

SOURCE Array BioPharma Inc.

Latest news about Array Technologies, Inc.

Piper Sandler Adjusts Price Target on Array Technologies to $13 From $12, Maintains Neutral Rating	Apr. 11	MT
Array Technologies, Inc. Announces Not Standing for Re-Election of Board of Directors	Apr. 10	CI
Guggenheim Raises Price Target on Array Technologies to $22 From $20, Maintains Buy Rating	Apr. 05	MT
North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ
Barclays Upgrades Array Technologies to Overweight From Equalweight, Raises Price Target to $18 From $15	Apr. 02	MT
Array Technologies, Inc. Launches Hail Alert Response	Mar. 26	CI
Array Technologies, Inc. Appoints James Zhu as Chief Accounting Officer	Mar. 22	CI
BMO Capital Initiates Coverage on Array Technologies With Market Perform Rating, $16 Price Target	Mar. 22	MT
KeyBanc Starts Array Technologies at Sector Weight, Sees Stock 'in Penalty Box' for Foreseeable Future Amid Outlook for Slow Recovery	Mar. 05	MT
UBS Adjusts Array Technologies Price Target to $22 From $30, Maintains Buy Rating	Feb. 29	MT
North American Morning Briefing : Fed's Preferred -2-	Feb. 29	DJ
Johnson Rice Cuts Price Target on Array Technologies to $25 From $30, Keeps Buy Rating	Feb. 28	MT
Cantor Fitzgerald Adjusts Price Target on Array Technologies to $18 From $22, Maintains Overweight Rating	Feb. 28	MT
Piper Sandler Adjusts Price Target on Array Technologies to $12 From $22, Maintains Neutral Rating	Feb. 28	MT
JPMorgan Cuts Price Target on Array Technologies to $29 From $35, Maintains Overweight Rating	Feb. 28	MT
Mizuho Securities Cuts Price Target on Array Technologies to $18 From $20, Maintains Neutral Rating	Feb. 28	MT
BNP Paribas Exane Downgrades Array Technologies to Underperform From Neutral	Feb. 28	MT
Array Technologies Q4 Adjusted Profit Rises, Revenue Declines	Feb. 28	MT
Transcript : Array Technologies, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Array Technologies, Inc. Provides Revenue Guidance for the Year Ending December 31, 2024	Feb. 27	CI
Array Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
Earnings Flash (ARRY) ARRAY TECHNOLOGIES Reports Q4 EPS $0.21, vs. Street Est of $0.11	Feb. 27	MT
Earnings Flash (ARRY) ARRAY TECHNOLOGIES Reports Q4 Revenue $341.6M, vs. Street Est of $316.1M	Feb. 27	MT
Array Technologies and Alupco® Announce Strategic Partnership to Fuel Growing Renewable Energy Market in the Middle East	Feb. 22	CI
Truist Adjusts Array Technologies' Price Target to $25 From $30, Maintains Buy Rating	Jan. 23	MT

Chart Array Technologies, Inc.

Duration

Period

More charts

Company Profile

Array Technologies, Inc. is a provider of utility-scale solar tracker technology. The Company manufactures ground-mounting tracking systems used in utility and distributed generation solar energy projects worldwide. The Companyâs segments include Array Legacy Operations and STI Legacy Operations. Its principal products are a portfolio of integrated solar tracking systems comprised of software and hardware that include, component parts, such as steel tubing, steel supports, drivelines, center structures, electric motors, motor controller assemblies, bearing assemblies, gearboxes and electronic controllers commonly referred to as a single-axis tracker. Its flagship tracker uses a patented design that allows one motor to drive multiple rows of solar panels. Its products and services include Tracker Systems; DuraTrack HZ v3; Array STI H250; Array OmniTrack, and SmarTrack Software. SmarTrack is its range of software and control-based products designed for utility-scale solar sites.

Sector

Renewable Energy Equipment & Services

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Array Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

11.69 USD

Average target price

20.22 USD

Spread / Average Target

+72.97%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Renewable Energy Equipment & Services

	1st Jan change	Capi.
ARRAY TECHNOLOGIES, INC.	-30.42%	1.77B
SUNGROW POWER SUPPLY CO., LTD.	+7.31%	19.19B
TRINA SOLAR CO., LTD.	-26.32%	6.3B
MING YANG SMART ENERGY GROUP LIMITED	-29.74%	2.65B
GOODWE TECHNOLOGIES CO., LTD.	-27.34%	2.26B
SHENZHEN HOPEWIND ELECTRIC CO., LTD.	-23.60%	1.17B
SMART GÜNES ENERJISI TEKNOLOJILERI ARASTIRMA VE GELISTIRME ÜRETIM SANAYI VE TICARET	+1.54%	1.05B
SHINFOX ENERGY CO., LTD.	+32.39%	934M
ENEFIT GREEN	-10.01%	900M
AZAD ENGINEERING LIMITED	+87.42%	919M

Other Renewable Energy Equipment & Services